By Ethan Covey
Cell-based and adjuvanted influenza vaccines can reduce the burden of seasonal influenza on hospitals and health systems, according to data presented at the 11th congress in the OPTIONS series, held in Belfast, Northern Ireland.
In the first study, a retrospective cohort design (poster P-328), researchers used electronic health records (EHRs) to estimate the relative effectiveness of adjuvanted trivalent vaccines (aTIV) (FLUAD, CSL Seqirus) compared with high-dose trivalent vaccine